CIK 0001053369
- Non-accelerated filer
- Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 223542636
- Phone
- +1 201-750-2646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- 4 Option exercise Chairman of the Board acquired 180,000 shares (option exercise)
- 5 Insider Annual Insider Trading Report
- 3/A Insider 3/A
- 4 Open-market sale Director sold 239,367 shares at $0.60 ($144,003)
- 4 Open-market sale Chief Scientific Officer sold 239,367 shares at $0.60 ($144,003)
- 4 Open-market sale 10% owner sold 239,367 shares at $0.60 ($144,003)
- 4 Open-market sale 10% owner sold 239,367 shares at $0.60 ($144,003)
- 4 Open-market sale Director sold 1,824,500 shares at an average $0.77 ($1,407,330)
- 4 Open-market sale Chief Scientific Officer sold 1,824,500 shares at an average $0.77 ($1,407,330)
- 4 Open-market sale 10% owner sold 1,824,500 shares at an average $0.77 ($1,407,330)
- 4 Open-market sale 10% owner sold 1,824,500 shares at an average $0.77 ($1,407,330)
- 4 Grant or award Director acquired 220,106 shares (grant or award)
- 4 Grant or award Chairman of the Board acquired 330,159 shares (grant or award)
- 4 Grant or award Director acquired 220,106 shares (grant or award)
- 4 Grant or award President & CEO acquired 2,616,580 shares (grant or award)
- 4 Grant or award CFO, Secretary, Treasurer acquired 330,159 shares (grant or award)
- 4 Conversion Chief Scientific Officer acquired 2,000,000 shares (conversion)
- 4 Grant or award Director acquired 220,106 shares (grant or award)
- 4 Conversion Chairman of the Board acquired 4.24 shares (conversion)
- 4 Conversion President & CEO acquired 100 shares (conversion)
Page 7 of 26 · 511 filings